Imiquimod: all 126 studies that test it
Page 1 of 2. Open to participants first (7), then studies with results posted, then the rest; newest registration first within each.
- Safety and Efficacy of Nivolumab and Imiquimod Combination in Vulvar Squamous Cell Carcinoma PatientsNot yet recruitingNCT07679841Phase 1/2
- Topical Imiquimod Treatment of Oral DysplasiaRecruitingNCT07210775Phase 1/2
- Deep Phenotyping of Cutaneous Lupus ErythematosusRecruitingNCT06411106Not applicable
- Clinical Outcome and Biomarkers for Predicting Immunological Response in Patients Treated with ImiquimodRecruitingNCT06356012Phase 4
- CD200AR-L and Allogeneic Tumor Lysate Vaccine Immunotherapy for Recurrent HGG and Newly Diagnosed DMG/DIPG in Children and Young AdultsRecruitingNCT06305910Phase 1
- Combining Topical Imiquimod With Local Radiotherapy for Treatment of Mycosis FungoidesRecruitingNCT05838599Early Phase 1
- Basal Cell Carcinoma Chemoprevention TrialRecruitingNCT05212246Phase 3
- Neoadjuvant Imiquimod Immunotherapy for Oral CancerCompletedNCT04883645Early Phase 1Results posted
- Genomic Markers Before and After Treatment of Actinic Keratosis With Imiquimod 3.75% CreamCompletedNCT03914417Phase 2Results posted
- Imiquimod for Preventing Keloid RecurrenceTerminatedNCT03760250Phase 2Results posted
- Imiquimod and Pembrolizumab in Treating Patients With Stage IIIB-IV MelanomaCompletedNCT03276832Early Phase 1Results posted
- Topical Fluorouracil and Imiquimod in Treating Patients With High-Grade Cervical Intraepithelial NeoplasiaCompletedNCT03196180Early Phase 1Results posted
- Evaluation of VGX-3100 and Electroporation Alone or in Combination With Imiquimod for the Treatment of HPV-16 and/or HPV-18 Related Vulvar HSIL (Also Referred as: VIN 2 or VIN 3)CompletedNCT03180684Phase 2Results posted
- Treatment of High-Grade Pre-Neoplastic Cervical Lesions (CIN 2/3)CompletedNCT02864147Phase 2Results posted
- Treatment in Preventing Anal Cancer in Patients With HIV and Anal High-Grade LesionsCompletedNCT02135419Phase 3Results posted
- A Study to Evaluate the Safety and Efficacy Imiquimod Cream, 2.5% in Participants With Actinic KeratosesCompletedNCT02120898Phase 3Results posted
- Imiquimod, Fluorouracil, or Observation in Treating HIV-Positive Patients With High-Grade Anal Squamous Skin LesionsCompletedNCT02059499Phase 3Results posted
- Toll-like Receptor (TLR) 7 Agonist, Cyclophosphamide, and Radiotherapy for Breast Cancer With Skin MetastasesCompletedNCT01421017Phase 1/2Results posted
- Therapeutic Vaccination for Patients With HPV16+ Cervical Intraepithelial Neoplasia (CIN2/3)CompletedNCT00988559Phase 1Results posted
- The Effects of Aldara as an Adjunct to Laser TreatmentTerminatedNCT00979550Phase 2Results posted
- Bioequivalence of Generic Imiquimod Cream, 5% When Compared to Aldara™ (Imiquimod) Cream, 5% in the Treatment of Actinic KeratosisCompletedNCT00948428Phase 3Results posted
- Imiquimod for Breast Cancer Patients With Chest Wall Recurrence or Skin MetastasesCompletedNCT00899574Phase 2Results posted
- Safety and Effectiveness Study of Actinic Keratosis Treatment Following CryosurgeryCompletedNCT00894647Phase 3Results posted
- Bioequivalence Study of Two Imiquimod Cream 5%CompletedNCT00828568Phase 1Results posted
- Topical Imiquimod and Abraxane in Treating Patients With Advanced Breast CancerCompletedNCT00821964Phase 2Results posted
- Vaccination of Patients With Ovarian Cancer With Dendritic Cell/Tumor Fusions With Granulocyte Macrophage Colony-stimulating Factor (GM-CSF) and ImiquimodTerminatedNCT00799110Phase 2Results posted
- Topical Imiquimod Cream in Combination With Cryotherapy for the Treatment of Actinic KeratosesCompletedNCT00774787Phase 4Results posted
- Phase 3 Study of Imiquimod Creams in the Treatment of External Genital WartsCompletedNCT00735462Phase 3Results posted
- Safety and Effectiveness Study of Imiquimod Creams in the Treatment of External Genital WartsCompletedNCT00674739Phase 3Results posted
- Topical Imiquimod in Conjunction With Nd:YAG Laser for Tattoo RemovalCompletedNCT00638651Phase 1Results posted
- Safety and Effectiveness Study of Imiquimod Creams for Treatment of Actinic Keratoses (AKs)CompletedNCT00605176Phase 3Results posted
- Safety and Effectiveness Study of Imiquimod Creams for the Treatment of Actinic Keratoses (AKs)CompletedNCT00603798Phase 3Results posted
- Combining Topical Imiquimod 5% Cream With a Pulsed Dye Laser to Treat Port Wine Stain BirthmarksCompletedNCT00585247Not applicableResults posted
- Topical Imiquimod in Treating Patients With Recurrent Paget's Disease of the VulvaCompletedNCT00504023Not applicableResults posted
- Mechanistically-based Optimization of UV Radiation Therapy in PsoriasisTerminatedNCT00470392Not applicableResults posted
- Evaluation of the Impact of Adjuvants Accompanying Peptide Immunization in High-Risk MelanomaCompletedNCT00273910Phase 2Results posted
- Open-label Study to Evaluate Clearance of Superficial Basal Cell Carcinoma After Use of Imiquimod 5% CreamCompletedNCT00189306Phase 3Results posted
- NY-ESO-1 Protein Vaccine With Imiquimod in Melanoma (Adjuvant Setting)CompletedNCT00142454Phase 1Results posted
- Open-Label Safety Study to Evaluate Imiquimod Cream, 5% for Large Areas of Actinic KeratosisCompletedNCT00116649Phase 4Results posted
- Investigating the Effect of Topical Imiquimod on Sebaceous HyperplasiaCompletedNCT06840470Phase 4
- Influenza Vaccine With Topical Imiquimod in Influenza Vaccine Non-responsive ChildrenStatus unknownNCT05315024Not applicable
- Evaluation of Intradermal Hepatitis B Vaccine After IMIQUIMOD's Application, in Cirrhotics Who Did Not Respond to the Usual Vaccine RegimenStatus unknownNCT05028322Phase 2
- Comparison of Treatment of Cervical Intraepithelial Lesions With Imiquimod or LLETZStatus unknownNCT04859361Not applicable
- Earliest Stage Treatment of Aktinic Keratosis With Imiquimod 3.75% CreamCompletedNCT04842422Phase 4
- Topical Application of Imiquimod Gel at Different Concentrations in Actinic CheilitisTerminatedNCT04219358Phase 1
- Intradermal Influenza Vaccine With Topical Imiquimod in Elderly and Chronic Illness PatientsStatus unknownNCT04143451Phase 3
- A Study to Evaluate Neoadjuvant Sonidegib Followed by Surgery or Imiquimod in the Management of Basal Cell CarcinomaCompletedNCT03534947Phase 2
- Adjuvant Anal Imiquimod Therapy in Anal HPV-lesions: AdAM-trialStatus unknownNCT03289260Phase 3
- Randomized Clinical Trial Evaluating the Efficacy of Topical Imiquimod in High Grade Cervical Intraepithelial LesionsCompletedNCT03233412Phase 2
- Safety and Efficacy of GX-188E Administered Via EP Plus GX-I7 or Imiquimod.Status unknownNCT03206138Not applicable
- CTCL Directed TherapyStatus unknownNCT03116659Early Phase 1
- Topical Challenge With Omiganan and Imiquimod in Healthy VolunteersCompletedNCT03071679Phase 1
- Imiquimod and Influenza Vaccine for Immunocompromised PatientsCompletedNCT02960815Phase 2
- Imiquimod Treatment of High-grade CINStatus unknownNCT02917746Not applicable
- Immunologic Profile of Chronically Photodamaged SkinCompletedNCT02889159Phase 1
- iVAC-CLL01: Patient-individualized Peptide Vaccination After First Line Therapy of CLLCompletedNCT02802943Phase 2
- Imiquimod Treatment of Residual or Recurrent CIN Lesions: a Study ProtocolStatus unknownNCT02669459Phase 3
- Peptide-specific Vaccination in HLA-A*02 Positive Patients With Biochemical Recurrence After Radical ProstatectomyStatus unknownNCT02452307Phase 1/2
- Radiotherapy or Imiquimod in Complex Lentigo MalignaCompletedNCT02394132Phase 3
- Topical 5% Imiquimod Cream for Vulvar Paget's DiseaseCompletedNCT02385188Phase 3
- Imiquimod Treatment of CIN LesionsTerminatedNCT02329171Phase 3
- Effectiveness of Imiquimod Topical Cream in Early Stage Cutaneous T-cell LymphomaWithdrawnNCT02301494Not applicable
- IM Versus 5-FU Versus IMI Versus MAL-PDT in Treatment of Actinic KeratosisStatus unknownNCT02281682Phase 4
- HER2-Peptide Vaccination of Patients With Solid TumorsCompletedNCT02276300Phase 1
- Surgery Versus Combined Treatment With Curettage and Imiquimod for Nodular Basal Cell CarcinomaStatus unknownNCT02242929Phase 3
- Pilot Study of DRibble Vaccine for Prostate Cancer PatientsCompletedNCT02234921Phase 1
- Topical Imiquimod vs. LEEP for Women With Carcinoma In-situ of the CervixCompletedNCT02130323Phase 2/3
- Intradermal Influenza Vaccine in the YoungCompletedNCT02103023Phase 3
- Photoaging Treatment With ImiquimodCompletedNCT01935310Not applicable
- Combination Vaccine Immunotherapy (DRibbles) for Patients With Definitively-Treated Stage III Non-small Cell Lung CancerCompletedNCT01909752Phase 2
- Primary Imiquimod Treatment Versus Surgery for Vulvar Intraepithelial NeoplasiaCompletedNCT01861535Phase 3
- Immunotherapy for Recurrent Ependymomas in Children Using Tumor Antigen Peptides With ImiquimodTerminatedNCT01795313Phase 1
- Study With TMX-101 in Patients With Carcinoma In Situ (CIS) Bladder CancerCompletedNCT01731652Phase 2
- Relevance of Imiquimod as Neo-adjuvant Treatment to Reduce Excision Size and the Risk of Intralesional Excision in Lentigo Malignant of the FaceCompletedNCT01720407Phase 3
- Imiquimod and Tumor Lysate Vaccine Immunotherapy in Adults With High Risk or Recurrent Grade II GliomasCompletedNCT01678352Early Phase 1
- Anal Dysplasia Study of Men Who Have Sex With Men Living With HIVWithdrawnNCT01663558Phase 4
- Efficacy and Safety of a New Topical Formulation With Imiquimod (Limtop) Applied 1, 3 or 7 Times Weekly During 2 x 2 Weeks Treatment for Actinic Keratosis on the HeadCompletedNCT01611480Phase 2
- Identification of Novel Biomarkers of Cervicovaginal Mucosal InflammationCompletedNCT01593124Phase 2
- A Double-blind, Randomized, Single Centre, Vehicle-controlled Study to Evaluate the Safety and Tolerability of a New Topical Formulation Containing 0,09% Imiquimod (Limtop) in Healthy SubjectsCompletedNCT01567683Phase 1
- Intradermal Trivalent Influenza Vaccine With ImiquimodCompletedNCT01508884Not applicable
- Long-term Effects of Imiquimod and Diclofenac in Actinic Keratoses (LEIDA 2)CompletedNCT01453179Phase 4
- Potential Effect of Topical Imiquimod on Atrial Ectopy in Patients With Actinic KeratosisStatus unknownNCT01413763Phase 4
- Imiquimod/Brain Tumor Initiating Cell (BTIC) Vaccine in Brain Stem GliomaTerminatedNCT01400672Phase 1
- Oral Miltefosine Plus Topical Imiquimod to Treat Cutaneous LeishmaniasisCompletedNCT01380314Phase 2
- Topical Imiquimod Versus Conization to Treat Cervical Intraepithelial NeoplasiaTerminatedNCT01283763Phase 3
- Imiquimod 3.75% Cream in Combination With Cryotherapy in the Treatment of Hypertrophic Actinic KeratosesStatus unknownNCT01229319Phase 4
- Effect of Topical Imiquimod on Lentigo MalignaCompletedNCT01161888Phase 4
- Imiquimod to Detect Residual Lesions and Prevent Recurrence of Lentigo MalignaStatus unknownNCT01088737Phase 2/3
- Comparison of Five Treatments in Patients With Plantar WartsTerminatedNCT01059110Phase 4
- Immunevasion of Human Papillomavirus (HPV) in Vulvar Intraepithelial Neoplasia 2/3 and Anogenital Warts and Efficiency and Mechanisms of Imiquimod TreatmentCompletedNCT00941811Phase 2
- ITIC (Imiquimod Therapy in Cervical Intraepithelial Neoplasia)-TrialCompletedNCT00941252Phase 2/3
- Topical Imiquimod 5% Cream for Treatment of Cutaneous Neurofibromas in Adults With Neurofibromatosis 1CompletedNCT00865644Phase 1
- A Randomized, Double-Blind, Parallel-Group, Vehicle-Controlled Therapeutic Equivalence Study of Three Imiquimod Cream 5% Treatments for Patients With Actinic KeratosisCompletedNCT00859105Phase 3
- Treatment Study for Actinic Cheilitis Comparing Imiquimod 5% and Photodynamic TherapyCompletedNCT00849992Phase 4
- Imiquimod 5% Cream for the Treatment of Periocular Basal Cell CarcinomaStatus unknownNCT00803907Phase 4
- Vaccine Therapy With or Without Imiquimod in Treating Patients With Grade 3 Cervical Intraepithelial NeoplasiaCompletedNCT00788164Phase 1
- IMA910 Plus GM-CSF With Low-dose Cyclophosphamide Pre-treatment in Advanced Colorectal Carcinoma Patients Following a Successful 12 Week First-line Treatment With Oxaliplatin-based Chemotherapy (IMA910-101)CompletedNCT00785122Phase 1/2
- Long-term Effects of Imiquimod and Diclofenac in Actinic KeratosesCompletedNCT00777127Phase 4
- Imiquimod 5% Cream in the Treatment of External Genital or Perianal Warts in HIV+ PatientsCompletedNCT00761371Phase 4
- Safety and Immunogenicity of CYT004-MelQbG10 Vaccine With and Without Adjuvant in Advanced Stage Melanoma PatientsCompletedNCT00651703Phase 2